Knowledge Center

Patent / Jan 01, 1966

Tetracycline process

Authors:
  • Ivan Villax
Source:
BE 658387

A newly isolated strain of Streptomyces lusitanus var tetracyclini NCIB 9500 produces tetracycline with no co-production of chlortetracycline in the presence of Cl-. Thus, in a 6000-1. fermentor, with corn-steep medium contg. 1.5 g. NH4Cl/l. the strain produces 11.1 g. tetracycline/l. and no detectable amt. of chlortetracycline.

Also in the Knowledge Center

Related Content

Spray drying

Spray drying has become one of the most successful particle engineering technologies for improving drug bioavailability through the amorphous solid dispersion platform.

Page
Read more

Virtual Tours

Our doors are open. Welcome to our facilities. We are a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more